Inventiva

IVANasdaq France Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$862.423 M

$3.65 -3.44%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

193,236,978

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#166ArdelyxARDX$872.2M
#167Avalo TherapeuticsAVTX$867.2M
#168InventivaIVA$862.4M
#169Faeth TherapeuticsFTH$860.2M
#170CybinHELP$846.7M

What if Inventiva were worth as much as…

Open the what-if tool →

Gold $30.3T

$128,127.76

Per share 35,103× higher

Bitcoin $1.72T

$7,278.66

Per share 1,994× higher

Nvidia $5.48T

$23,192.20

Per share 6,354× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Inventiva are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.